Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.

Area of Science:

• Comparative oncology
• Genomics
• Translational research

Background:

• Osteosarcoma is an aggressive bone cancer in humans and dogs with poor survival outcomes, often due to metastasis.
• Canine osteosarcoma closely mimics human disease biologically and clinically, offering a valuable comparative model.
• Despite advances, current therapies are suboptimal, highlighting the need for novel treatment strategies.

Purpose of the Study:

• To explore the potential of comparative genomic studies across human, canine, and mouse osteosarcoma models.
• To identify commonly affected and targetable molecular pathways for developing new therapies.
• To advance translational research from preclinical models to clinical applications.

Main Methods:

• Review of existing literature on osteosarcoma genomics in humans, dogs, and mice.
• Analysis of genetic similarities and differences, including chromosomal aberrations and gene expression.
• Examination of spontaneous and genetically engineered mouse models for osteosarcoma research.

Main Results:

• Osteosarcoma exhibits complex karyotypes and similar molecular alterations (e.g., TP53, RB pathway loss) in humans and dogs.
• Commonly amplified oncogenes like MYC and RAS are observed, but no single proto-oncogene target has emerged.
• Genomic complexity hinders definitive identification of therapeutic targets, necessitating advanced research models.

Conclusions:

• Comparative genomics between human, canine, and mouse osteosarcoma models holds promise for discovering shared therapeutic targets.
• Identifying recurrent gene expression changes and epigenetic alterations could lead to novel targeted therapies.
• A translational pathway from mouse models to canine and human patients may accelerate the development of effective osteosarcoma treatments.